 |
PDBsum entry 2b5k
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Antimicrobial protein
|
PDB id
|
|
|
|
2b5k
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Biochemistry
44:15504-15513
(2005)
|
|
PubMed id:
|
|
|
|
|
| |
|
Solution structure and interaction of the antimicrobial polyphemusins with lipid membranes.
|
|
J.P.Powers,
A.Tan,
A.Ramamoorthy,
R.E.Hancock.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The horseshoe crab cationic antimicrobial peptide polyphemusin I is highly
active in vitro but not protective in mouse models of bacterial and LPS
challenge, while a synthetic polyphemusin variant, PV5, was previously shown to
be protective in vivo. In this study, we investigated the interaction of these
peptides with lipid membranes in an effort to propose a mechanism of
interaction. The solution structure of PV5 was determined by proton NMR in the
absence and presence of dodecylphosphocholine (DPC) micelles. Like polyphemusin
I, PV5 is a beta-hairpin but appeared less amphipathic in solution. Upon
association with DPC micelles, PV5 underwent side chain rearrangements which
resulted in an increased amphipathic conformation. Using fluorescence
spectroscopy, both peptides were found to have limited affinity for neutral
vesicles composed of phosphatidylcholine (PC). Incorporation of 25 mol %
cholesterol or phosphatidylethanolamine into PC vesicles produced little change
in the partitioning of either peptide. Incorporation of 25 mol %
phosphatidylglycerol (PG) into PC vesicles, a simple prokaryotic model, resulted
in a large increase in the affinity for both peptides, but the partition
coefficient for PV5 was almost twice that of polyphemusin I. Differential
scanning calorimetry studies supported the partitioning data and demonstrated
that neither peptide interacted readily with neutral PC vesicles. Both peptides
showed affinity for negatively charged membranes incorporating PG. The affinity
of PV5 was much greater as the pretransition peak was absent at low peptide to
lipid ratios (1:400) and the reduction in enthalpy of the main transition was
greater than that produced by polyphemusin I. Both peptides decreased the
lamellar to inverted hexagonal phase transition temperature of PE indicating the
induction of negative curvature strain. These results, combined with previous
findings that polyphemusin I promotes lipid flip-flop but does not induce
significant vesicle leakage, ruled out the torroidal pore and carpet mechanisms
of antimicrobial action for these polyphemusins.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
K.Splith,
and
I.Neundorf
(2011).
Antimicrobial peptides with cell-penetrating peptide properties and vice versa.
|
| |
Eur Biophys J,
40,
387-397.
|
 |
|
|
|
|
 |
F.S.Nandel,
and
T.R.Sahrawat
(2009).
Conformational study of poly-DeltaAbu peptides and construction of amphipathic nanostructure.
|
| |
Biopolymers,
92,
44-51.
|
 |
|
|
|
|
 |
L.M.Gottler,
and
A.Ramamoorthy
(2009).
Structure, membrane orientation, mechanism, and function of pexiganan--a highly potent antimicrobial peptide designed from magainin.
|
| |
Biochim Biophys Acta,
1788,
1680-1686.
|
 |
|
|
|
|
 |
A.A.Langham,
H.Khandelia,
B.Schuster,
A.J.Waring,
R.I.Lehrer,
and
Y.N.Kaznessis
(2008).
Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity.
|
| |
Peptides,
29,
1085-1093.
|
 |
|
|
|
|
 |
E.Fleming,
N.P.Maharaj,
J.L.Chen,
R.B.Nelson,
and
D.E.Elmore
(2008).
Effect of lipid composition on buforin II structure and membrane entry.
|
| |
Proteins,
73,
480-491.
|
 |
|
|
|
|
 |
K.F.Lin,
T.R.Lee,
P.H.Tsai,
M.P.Hsu,
C.S.Chen,
and
P.C.Lyu
(2007).
Structure-based protein engineering for alpha-amylase inhibitory activity of plant defensin.
|
| |
Proteins,
68,
530-540.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.A.Fázio,
L.Jouvensal,
F.Vovelle,
P.Bulet,
M.T.Miranda,
S.Daffre,
and
A.Miranda
(2007).
Biological and structural characterization of new linear gomesin analogues with improved therapeutic indices.
|
| |
Biopolymers,
88,
386-400.
|
 |
|
|
|
|
 |
A.Ramamoorthy,
S.Thennarasu,
A.Tan,
K.Gottipati,
S.Sreekumar,
D.L.Heyl,
F.Y.An,
and
C.E.Shelburne
(2006).
Deletion of all cysteines in tachyplesin I abolishes hemolytic activity and retains antimicrobial activity and lipopolysaccharide selective binding.
|
| |
Biochemistry,
45,
6529-6540.
|
 |
|
|
|
|
 |
H.Jenssen,
P.Hamill,
and
R.E.Hancock
(2006).
Peptide antimicrobial agents.
|
| |
Clin Microbiol Rev,
19,
491-511.
|
 |
|
|
|
|
 |
J.P.Powers,
M.M.Martin,
D.L.Goosney,
and
R.E.Hancock
(2006).
The antimicrobial peptide polyphemusin localizes to the cytoplasm of Escherichia coli following treatment.
|
| |
Antimicrob Agents Chemother,
50,
1522-1524.
|
 |
|
|
|
|
 |
S.Abu-Baker,
and
G.A.Lorigan
(2006).
Phospholamban and its phosphorylated form interact differently with lipid bilayers: a 31P, 2H, and 13C solid-state NMR spectroscopic study.
|
| |
Biochemistry,
45,
13312-13322.
|
 |
|
|
|
|
 |
Y.A.Domanov,
and
P.K.Kinnunen
(2006).
Antimicrobial peptides temporins B and L induce formation of tubular lipid protrusions from supported phospholipid bilayers.
|
| |
Biophys J,
91,
4427-4439.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |